PharVision Advisers’s Himax Technologies HIMX Stock Holding History

PharVision Advisers’s Portfolio HIMX Stock Details HIMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,474	Closed	-$98.2K	–	89
2026 Q1	$98.2K	Buy	+12,474	New	+$102K	1%	48

Other funds holding HIMX

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PharVision Advisers's HIMX Position: Q2 2026 in Review

PharVision Advisers sold out of Himax Technologies (HIMX) in Q2 2026, closing a stake of 12,474 shares — an estimated $98.2K sold.

PharVision Advisers first reported a position in HIMX in Q1 2026 and held it in 1 quarter. The position peaked at $98.2K in Q1 2026. 176 funds tracked by Wall St. Rank hold HIMX as of Q2 2026.

PharVision Advisers reported no remaining Himax Technologies position as of Q2 2026 after selling out during the quarter.
PharVision Advisers sold 12,474 Himax Technologies shares in Q2 2026, an estimated $98.2K.
PharVision Advisers first reported a position in Himax Technologies in Q1 2026 and held it in 1 quarter.
PharVision Advisers's Himax Technologies position peaked at $98.2K in Q1 2026.
176 funds tracked by Wall St. Rank held Himax Technologies as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.